Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

K14 in Urothelial Cells as a Pronostic and Diagnostic Marker in Bladder Cancer Patients Using a Non Invasive Technique.

NCT02027649 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT02027649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02027649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
K14 in Urothelial Cells as a Pronostic and Diagnostic Marker in Bladder Cancer Patients Using a Non Invasive Technique.
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Terminated
Start date
January 31, 2014
Completion date
May 31, 2017
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer